Bernstein analyst Eve Burstein lowered the firm’s price target on Thermo Fisher (TMO) to $620 from $625 and keeps a Market Perform rating on the shares following quarterly results. The firm notes organic revenue growth of 0% was in line with expectations, though the reported revenue slightly missed expectations, as did adjusted operating income. A small EPS beat was driven by interest/other expense. The company maintained its revenue guide for FY24, and raised the bottom of its EPS guide, Bernstein adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target lowered to $622 from $632 at Baird
- Thermo Fisher price target lowered to $660 from $670 at Wells Fargo
- Thermo Fisher price target lowered to $610 from $620 at Barclays
- Thermo Fisher Scientific Reports Earnings: Did it Beat Estimate Forecasts?
- Thermo Fisher sees Q4 EPS $5.96, consensus $5.98